Subscribe free

HPB & Spleen ·

FGFR2 Alterations Enhance Survival in iCCA Patients

Meta-analysis reveals patients with intrahepatic cholangiocarcinoma (iCCA) and FGFR2 alterations have significantly better overall survival outcomes compared to those without. Results suggest FGFR2 alterations could serve as a promising therapeutic target for managing iCCA, especially in cases of metastatic or unresectable tumors. This study presents innovative insights into targeted therapy for iCCA, highlighting the potential benefits of FGFR2-targeted treatments in improving patient prognosis.

Review by Niu S, Zhang Y, Li Z and Wang T in Liver Int

© 2024 The Author(s). Liver International published by John Wiley & Sons Ltd.

read the whole article in Liver Int

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in HPB & Spleen.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in HPB & Spleen

The latest stitches

Surg Endosc6 Nov 2026

A new cut for robotic liver surgery

A close-to-open cutting method was used for robotic liver resection, with no bile leaks and shorter hospital stays than after laparoscopy.

Surg Endosc6 Nov 2026

Robotic bile duct stone surgery: fewer complications

Removing large common bile duct stones with a robot rather than laparoscopically was linked to fewer complications and shorter hospital stays, at a higher cost, in a study from one Chinese hospital.

All papers in HPB & Spleen →